Summary:
A Randomized, Double-Blind, Active-Controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder
Qualified participants must be 18-65 years old and meet the criteria for depression. Participants must also have an inadequate response to previous treatments for depression.
Qualified Participants May Receive:
If qualified you will receive compensation for time and travel and may receive investigational medication or placebo.